Funding: Wellcome Trust Sanger Institute12 February 2007 The Wellcome Trust Sanger Institute was awarded £340 million for 2006–11, following a review of its achievements over the past five years. |
|
The Wellcome Trust Sanger Institute is the only research centre directly funded by the Wellcome Trust. In October 2005 it was awarded £340m to support its activities over the five-year period 2006–11.
During this period the Sanger Institute will drive forward its revised scientific strategy. Under Professor Allan Bradley, who took over as Director in 2000, its emphasis has shifted from genome sequencing to large-scale studies aimed at understanding the function of genes and their contributions to health and disease.
The new strategy will see a further refinement of this approach, with an enhanced focus on the Sanger Institute's core strengths: large-scale studies of natural and engineered variation in genome sequence, in humans, pathogens and model organisms (see Bred for success and Wellcome Trust Genome Campus).
Underpinning these major programmes will be the Sanger Institute's unique skills in informatics and high-throughput technologies such as sequencing and large-scale engineering of gene knockouts in the mouse.
Image: Wellcome Trust Sanger Institute